BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen D, Zhang Y, Shi F, Zhu H, Li M, Luo J, Chen K, Kong L, Yu J. Intrapericardial bevacizumab safely and effectively treats malignant pericardial effusion in advanced cancer patients. Oncotarget. 2016;7:52436-52441. [PMID: 27203219 DOI: 10.18632/oncotarget.9420] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Maisch B, Ristić AD, Pankuweit S, Seferovic P. Percutaneous Therapy in Pericardial Diseases. Cardiology Clinics 2017;35:567-88. [DOI: 10.1016/j.ccl.2017.07.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
2 Chen D, Song X, Zhang Y, Kong L, Wang H, Yu J. Optimizing intrapleural bevacizumab dosing in non-small-cell lung cancer-mediated malignant pleural effusion: less is more. Future Oncol 2018;14:2131-8. [PMID: 29546764 DOI: 10.2217/fon-2018-0089] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
3 Mufti M, Ching S, Farjami S, Shahangian S, Sobnosky S. A Case Series of Two Patients Presenting With Pericardial Effusion as First Manifestation of Non-Small Cell Lung Cancer With BRAF Mutation and Expression Of PD-L1. World J Oncol 2018;9:56-61. [PMID: 29760834 DOI: 10.14740/wjon1092w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
4 Chen D, Song X, Shi F, Zhu H, Wang H, Zhang N, Zhang Y, Kong L, Yu J. Greater efficacy of intracavitary infusion of bevacizumab compared to traditional local treatments for patients with malignant cavity serous effusion. Oncotarget 2017;8:35262-71. [PMID: 27823984 DOI: 10.18632/oncotarget.13064] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
5 Donisan T, Balanescu DV, Palaskas N, Lopez-Mattei J, Karimzad K, Kim P, Charitakis K, Cilingiroglu M, Marmagkiolis K, Iliescu C. Cardiac Interventional Procedures in Cardio-Oncology Patients. Cardiol Clin 2019;37:469-86. [PMID: 31587788 DOI: 10.1016/j.ccl.2019.07.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Chang HM, Okwuosa TM, Scarabelli T, Moudgil R, Yeh ETH. Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 2. J Am Coll Cardiol 2017;70:2552-65. [PMID: 29145955 DOI: 10.1016/j.jacc.2017.09.1095] [Cited by in Crossref: 110] [Cited by in F6Publishing: 93] [Article Influence: 22.0] [Reference Citation Analysis]
7 Capaccione KM, Huang S, Toor Z, May B, Deng A, Salvatore MM. Immunotherapy related pericardial effusion on chest CT. Clin Imaging 2021;82:204-9. [PMID: 34890964 DOI: 10.1016/j.clinimag.2021.11.029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Zhang Y, Zou JY, Xu YY, He JN. Fruquintinib beneficial in elderly patient with neoplastic pericardial effusion from rectal cancer: A case report. World J Clin Cases 2021; 9(21): 6170-6177 [PMID: 34368339 DOI: 10.12998/wjcc.v9.i21.6170] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Zhang J, Zhang Q, Chen X, Zhang N. Management of neoplastic pericardial disease. Herz 2020;45:46-51. [PMID: 31297544 DOI: 10.1007/s00059-019-4833-4] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]